期刊文献+

水蛭素影响SAH模型大鼠基底动脉蛋白酶激活受体1表达变化 被引量:1

Roles of hirudin in protease activated receptor 1 expression changes in basal artery of rat subaraclmoid hemorrhage models
原文传递
导出
摘要 目的探讨凝血酶抑制剂水蛭素对蛛网膜下腔出血(SAH)模型大鼠血管痉挛的影响及其作用机制。方法7周龄清洁级SD大鼠36只按照随机数字表法分为3组:对照组(12只1、SAH组(12只)、SAH+水蛭素组(12只),后两组采用二次注血法制作成SAH模型,SAH+水蛭素组同时注入水蛭索200U/mL血液。观察各组大鼠的行为学改变,并于术后7d在显微镜下观察基底动脉HE染色组织学形态,Image-ProPlus6.0图像分析软件测量基底动脉管腔横截面积,免疫组化染色检测基底动脉标本蛋白酶激活受体1(PAR-1)表达。结果基底动脉HE染色可见对照组血管管腔最大,管壁薄,内膜光滑无褶皱;SAH组基底动脉管腔窄,管壁厚,内皮褶皱;SAH+水蛭素组管壁及管径变化介于对照组与SAH组之间。并且SAH+水蛭素组管腔横截面积较SAH组明显大,SAH组、SAH+水蛭素组管腔横截面积较对照组明显小,差异均有统计学意义(P〈0.05)。免疫组化染色结果显示SAH组和SAH+水蛭素组基底动脉血管内皮细胞及平滑肌细胞的胞浆及胞核中均可见PAR-1阳性表达,其中SAH组表达较强,SAH+水蛭素组表达较弱,并且SAH+水蛭素组PARl吸光度值较SAH组明显低,SAH+水蛭素组、SAH组PAR-1吸光度值较对照组明显高,差异均有统计学意义(P〈0.05)。结论水蛭素注入蛛网膜下腔后可降低PAR-1的表达,能缓解基底动脉血管痉挛表现,提示凝血酶在SAH模型大鼠脑血管痉挛的发生发展过程中发挥了重要作用。 Objective To discuss the influence of direct thrombin inhibitor hirudin in the expression ofprotease activated receptor 1 (PAR-1) in basilar artery of the rat model with subarachnoid hemorrhage (SAH). Methods Thirty-six Spragne Dawley rats (7 weeks old, clearanimal) were divided into 3 groups randomly: control group (n=12), SAH group (n=12) and SAH+hirudin treatment group (n=12). The rat models of SAH in the later two groups were induced by twice injection blood into the cistema magna; rats in the SAH+hirudin treatment group also accepted blood with 200 U/mL hirudin. Animal behavior changes were recorded. Rats of different groups were killed on the 7~ d of model making, and samples of basilar artery were performed HE staining for histological observation under microscope; vascular changes of cross-sectional area were measured by Image-Pro Plus6.0 imaging analysis software; and PAR-1 expression was detected by immunohistochemistry. Results Larger vascular lumen, thinner wall, smoother lining and no fold in the basal artery of control group were found as compared with thick wall, narrow lumen and endothelial fold in SAH model rats; the changes of basal artery in SAH+hirudin treatment group enjoyed in the medium ranking. The vascular changes of cross-sectional area in the SAH+hirudin treatment group were more obvious than those in the SAH group (P〈0.05); the cross-sectional area in the SAH+hirudin treatment group and SAH group was significantlysmaller than that in the control group (P〈0.05). The immunohistochemistry results showed there was no PAR-1 expression in the rats of control group, and PAR-1 positively expressed in the basilar artery of rats in the SAH group and weakly expressed in that of SAH+hirudin treatment group. The PAR-1 absorbance value in the SAH+hirudin treatment group and SAH group was significantly higher than that in the control group; and that in the SAH+hirudin treatment group was significantly lower than that in the SAH group (P〈0.05). Conclusion Hirudin can reduce PAR-1 expression in the basilar artery of SAH rat models and relieve artery vasospasm, which indicates that thrombin may play important roles in the pathological process of cerebral vasospasm after SAH.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2013年第11期1123-1127,共5页 Chinese Journal of Neuromedicine
基金 海南省卫生厅科研课题(琼卫2010-64)
关键词 蛛网膜下腔出血 脑血管痉挛 凝血酶 水蛭素 蛋白酶激活受体1 Subarachnoid hemorrhage Cerebral vasospasm Thrombin Hirudin Protease activated receptor 1
  • 相关文献

参考文献16

  • 1Tsurutani H, Ohkuma H, Suzuki S. Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model [J]. Stroke, 2003, 34 (6): 1497-1500.
  • 2Zhang Z, Nagata I, Kikuchi H, et al. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm aler subaraehnoid hemorrhage: vasospasm caused by cistemal injection of recombinant platelet-derived growth factor- BB [J]. Stroke, 2001, 32(7): 1665-1672.
  • 3Borsody MK, DeGiovarmi GM, Marton LS, et al. Thrombin reduces cerebral arterial contractions caused by cerebrospinal fluid from patients with subarachnoid hemorrhage [J]. Stroke, 2000, 31 (9): 2149-2156.
  • 4Endo S, Branson P J, Alksne JF. Experimental model of symptomatic vasospasm in rabbits[J]. Stroke, 1988, 19(11): 1420-1425.
  • 5Hirano K. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology [J]. Arterioscler Thromb Vasc Biol, 2007, 27(1): 27-36.
  • 6Kai Y, Maeda Y, Sasaki T, et al. Basic and translational research on proteinase-activated receptors: the role of thrombin receptor in cerebral vasospasm in subaractmoid hemorrhage [J]. J Pharmaeol Sci, 2008, 108(4): 426-432.
  • 7Crowley RW, Model R, KasseU NF, el al. New insights into the causes and therapy of cerebral vasospasm following subarachnoid hemorrhage[J]. Drug Discov Today, 2008, 13(5-6): 254-260.
  • 8Kudo A, Suzuki M, Kubo Y, et al. Intrathecal administration of thrombin inhibitor ameliorates cerebral vasospasm. Use of a drug delivery system releasing hirudin[J]. Cerebrovasc Dis, 2000, 10(6): 424-430.
  • 9Kameda K, KJkkawa Y, Hirano M, et al. Combined argatroban and anti-oxidative agents prevents increased vascular contractility to thrombin and other ligands after subarachnoid haemorrhage[J]. Br J Pharmacol. 2012, 165(1): 106-119.
  • 10Xue M, Fan Y, Liu S, et al. Contributions of multiple proteases to neurotoxicity in a mouse model of intracerebral haemorrhage [J]. Brain, 2009, 132(Pt 1): 26-36.

同被引文献28

  • 1Cannon JR, Keep RF, Schallert T, et al. Protease-activated receptor- 1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson's disease[J]. Brain Res, 2006, 1116(1): 177-186.
  • 2Arachiche A, Mumaw MM, de la Fuente M, et al. Protease- activated receptor 1 (PAR1) and PAR4 heterodimers are required for PARl-enhanced cleavage of PAR4 by tx-thrombin [J]. J Biol Chem, 2013, 288(45): 32553-32562.
  • 3Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis [J]. Yonsei Med J, 2010, 51(6): 808-822.
  • 4Striggow F, Riek-Burchardt M, Kiesel A, et al. Four different types of protease- activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia[J]. Eur J Neurosci, 2001, 14(4): 595-608.
  • 5Ishida Y, Nagai A, Kobayashi S, et al. Upregulation of protease-activated receptor-1 in astrocytes in Parkinson disease: astrocyte-mediated neuroprotection through increased levels of glutathione peroxidase[J]. J Neuropathol Exp Neurol, 2006, 65(1): 66-77.
  • 6Hirano K, Hirano M. Current perspective on the role of the thrombin receptor in cerebral vasospasm after subarachnoid hemorrhage[J]. J Pharmacol Sci, 2010, 114(2): 127-133.
  • 7Noorbakhsh F, Vergnolle N, McArthur JC, et al. Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection[J]. J Immunol, 2005, 174(11): 7320-7329.
  • 8Pompili E, Nori SL, Geloso MC, et al. Trimethyltin-induced differential expression of PAR subtypes in reactive astrocytes of the rat hippocampus[J]. Brain Res Mol Brain Res, 2004, 122(1): 93-98.
  • 9Henrich-Noack P, Riek-Burchardt M, Baldauf K, et al. Focal ischemia induces expression of protease-activated receptor1 (PAR1) and PAR3 on microglia and enhances PAR4 labeling in the penumbra[J]. Brain Res, 2006, 1070(1): 232-241.
  • 10Grammas P, Ottman T, Reimann-Philipp U, et al. Injured brain endothelial ceils release neurotoxic thrombin[J]. J Alzheimers Dis, 2004, 6(3): 275-281.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部